TrialAmerican journal of respiratory and critical care medicine2024

Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.

Ava Y Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.